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1. Introduction 
The human erythrocyte membrane has been exten- 
sively studied as a general membrane model [1,2]. It 
provides the best example of phospholipid assymmetry 
in biological membranes [3]. Phosphatidylcholine 
(PC) and sphingomyelin (SPH) are mainly present in 
the outer lipid layer whereas the major part of the 
amino phospholipids, phosphatidylethanolamine (PE) 
and phosphatidylserine (PS) reside inside [4]. The 
mechanism(s) by which the asymmetric distribution 
is generated and maintained is obscure although evi- 
dence is accumulating which suggests an important 
role for proteins in the stabilization of phospholipid 
distribution [5,6]. 
If and how intrinsic membrane proteins do effect 
phospholipid distribution could be studied using mem- 
brane mutants. We have used red cells of the rare 
blood group variant En(a-) which lack the main red 
cell sialoglycoprotein A [7-9] to study phospholipid 
distribution. These data show that the phospholipid 
distribution is, with respect to the polar head groups, 
completely normal which implies that glycophorin A
does not play a dominating role in maintenance of
phospholipid istribution in the human red cell mem- 
brane. 
2. Materials and methods 
En(a-) red cells and control erythrocytes, simul- 
taneously drawn, were obtained through the Red 
Cross Blood Transfusion Service, Helsinki and analyzed 
24 h later in Utrecht. The ceils were washed 3 times 
in a buffer containing 150 mM NaC1, 3 mM sodium 
azide, 25 mM glucose and 10 mM Tris-HC1 (pH 7.4) 
(STEG) buffer. After the final wash the packed cells 
were suspended in 3 vol. STEG buffer. Part of the 
cells (a 0.5 ml suspension) was spun down immediately, 
lysed in 10 mM EDTA made in water and frozen 
under Nz. This material was used for phospholipid 
analysis of whole membranes. Another 0.5 ml of the 
suspension was incubated in a final volume of 2 ml 
STEG buffer containing 10 mM CaC12 and 20 IU 
phospholipase Az from Na]a na]a (Sigma, St Louis) 
at 37°C on a clinical blood rotator for 2 h. The cells 
were then washed with STEG buffer containing 10 
mM EDTA, lysed in 10 mM EDTA and frozen. A 
third identical sample was incubated with phospho- 
lipase A2 as above but for 1 h only. Twenty IU of 
sphingomyelinase (Staphylococcus aureus), purified 
according to [ 10], were then added and the incubation 
was continued for another 1 h. Subsequent washings 
were carried out as above. The lipids were extracted, 
according to [11 ], and separated by two-dimensional 
thin-layer chromatography [ 12]. Phosphorus was 
determined as in [13]. 
3. Results 
As reported in [14], the En(a-) membranes have a 
phospholipid composition which is virtually identical 
to the composition of control erythrocytes. The result 
of 3 independent analyses showed that of the total 
phospholipid content 29.5% was PC, 25.3% was SPH, 
25.9% was PE and 12.2% was PS. The residual being 
lyso-PC 1.8 and minor phospholipids. 
Incubation of En(a-) and control erythrocytes 
with phospholipase A2 resulted in identical hydrolysis 
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Table 1 
Degradation ofphosphotipids in intact erythrocytes byphospholipase A 2and 
sphingomyelinase 
Control En (a-) Data from [4] 
PL-ase Az SPH-ase PL-ase A 2 SPH-ase PL-ase A~ SPH-ase 
A PC 67 ± 0.9 78 ± 1.5 64 ± 0.5 78 -+ 1.6 68 76 
2x SPH 79 ± 0.9 80 +- 2.0 82 
PS 8+0.3 2+0.3 
/, PE 4 +- 0.7 21 + 0.7 5 +- 0.8 17 + 1.4 8 20 
Cells, control and En (a-), were incubated with phospholipase A 20PL-ase A:) 
"alone or in combination with sphingomyelinase (SPH-ase) as in section 2. The 
amount of residual phospholipid was analyzed. The table shows the amount of 
each lipid class that can be hydrolyzed in the intact cells given in % of the total 
amount of the respective phospholipid present, The last 2 columns are taken from 
[4] for comparison. The results are means of 3 determinations -+ SD values 
patterns. Table 1 summarizes these data and the results 
in [4]. From the total PC, 67% and 64% was hydro- 
lyzed by phospholipase A2 in control and En(a- )  
cells, respectively, which is in good agreement with 
data published for normal cells. Also similar amounts 
of PE were hydrolyzed. Subsequent treatment with 
sphingomyelinase resulted in the hydrolysis of 78% 
of the PC, 17-21% of the PE, 78-80% of the sphin- 
gomyelin and a minimal amount of PS. Again these 
data confer to those published (see table 1). 
We can conclude that, as in normal erythrocytes, the 
En(a - )  erythrocytes have an asymmetric phospho- 
lipid distribution: 78% of the PC, 80% of the sphin- 
gomyelin and ~20% of the PE is present in the outer 
layer of  the membrane, the residual being inside. In 
various other aspects En(a - )  cells behaved uring 
lipolytic treatment like control cells: no lysis was 
observed, echinocytes were formed by phospholip- 
ase A2 treatment alone and the combined action of 
both phospholipases resulted in the formation of 
stomatocytes. 
4. Discussion 
Normal human erythrocyte membranes have an 
asymmetric phospholipid istribution [3,4]. The 
reason for the generation and maintenance of this 
asymmetry has, however, remained unclear. One 
attractive possibility would be that the asymmetry is
due to specific intrinsic membrane proteins. The 
major red cell sialoglycoprotein, glycophorin A, is 
one of the best characterized intrinsic membrane gly- 
coproteins [1,2]. It contains an intramembraneous 
hydrophobic amino acid sequence which evidently 
interacts with membrane lipids. Normal cells contain 
~106 copies of glycophorin A/cell [15], whereas 
En(a - )  red cells completely lack the protein [9,16]. 
The availability of this naturally occurring red cell 
variant gives an excellent possibility to study the 
influence of glycophorin A on the structure and func- 
tion of red cell membranes. 
Earlier studies have shown alterations in the En(a- )  
red cell membrane vidently secondary to the absence 
of glycophorin A. The band 3 protein is overglycosy- 
lated [7,17], but its rotational diffusion in the mem- 
brane was not changed although it normally seems to 
be associated with glycophorin A [18]. However, 
studies using spin-labelled fatty acids showed that the 
core region of En(a - )  membranes was more fluid 
than that of normal membranes [19]. Furthermore, 
external labeUing with trinitrobenzenesulfonate more 
efficiently labelled PE of En(a- )  cells that that of 
normal cells [14]. These results indicated a changed 
phospholipid bilayer. 
The phospholipid localization of En(a- )  mem- 
branes has now been studied in more detail using non- 
penetrating phospholipases. The results clearly show 
that the distribution of the major phospholipids i  
not changed from that of normal cells. This fact 
clearly rules out an involvement of glycophorin A in 
this phenomenon. 
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